Cargando…

Cannabinoids and their therapeutic applications in mental disorders 

Mental disorders represent a significant public health burden worldwide due to their high prevalence, chronically disabling nature, and substantial impact on quality of life. Despite growing knowledge of the pathological mechanisms that underlie the development of these disorders, a high percentage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scherma, Maria, Muntoni, Anna Lisa, Riedel, Gernot, Fratta, Walter, Fadda, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Les Laboratoires Servier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605020/ https://www.ncbi.nlm.nih.gov/pubmed/33162770 http://dx.doi.org/10.31887/DCNS.2020.22.3/pfadda

Ejemplares similares

New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders
por: Scherma, Maria, et al.
Publicado: (2018)

Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research
por: Melas, Philippe A., et al.
Publicado: (2021)

Synaptoproteomic Analysis of the Prefrontal Cortex Reveals Spatio-Temporal Changes in SYNGAP1 Following Cannabinoid Exposure in Rat Adolescence
por: Qvist, Johanna S., et al.
Publicado: (2022)

Anaplastic Lymphoma Kinase Receptor: Possible Involvement in Anorexia Nervosa
por: Dedoni, Simona, et al.
Publicado: (2023)

Δ(9)-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation
por: Lecca, Salvatore, et al.
Publicado: (2019)

Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine
por: Scherma, Maria, et al.
Publicado: (2020)

K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
por: Dedoni, Simona, et al.
Publicado: (2022)

Limited Access to a High Fat Diet Alters Endocannabinoid Tone in Female Rats
por: Satta, Valentina, et al.
Publicado: (2018)

Induction of Activity-Regulated Cytoskeleton-Associated Protein and c-Fos Expression in an Animal Model of Anorexia Nervosa
por: Scherma, Maria, et al.
Publicado: (2023)

Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study
por: Primavera, Diego, et al.
Publicado: (2017)

Beyond THC: The New Generation of Cannabinoid Designer Drugs
por: Fattore, Liana, et al.
Publicado: (2011)

Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood
por: Kononoff, Jenni, et al.
Publicado: (2018)

Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid
por: Justinova, Zuzana, et al.
Publicado: (2013)

Enhanced self-administration of the CB(1) receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms
por: Amchova, Petra, et al.
Publicado: (2014)

Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders
por: Manchia, Mirko, et al.
Publicado: (2022)

Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure
por: Garza-Cervantes, J. A., et al.
Publicado: (2020)

Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment
por: Pérez, Rebeca, et al.
Publicado: (2022)

Neurochemical, histological, and behavioral profiling of the acute, sub‐acute, and chronic MPTP mouse model of Parkinsonʼs disease
por: Santoro, Matteo, et al.
Publicado: (2022)

Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients
por: Isayeva, Ulker, et al.
Publicado: (2022)

Δ9-Tetrahydrocannabinol Prevents Methamphetamine-Induced Neurotoxicity
por: Castelli, M. Paola, et al.
Publicado: (2014)

The Transdermal Delivery of Therapeutic Cannabinoids
por: Mahmoudinoodezh, Haleh, et al.
Publicado: (2022)

Therapeutic Potential of Cannabinoids in Glaucoma
por: Lindner, Theresa, et al.
Publicado: (2023)

Cannabinoid Modulation of Neuroinflammatory Disorders
por: Saito, Viviane M, et al.
Publicado: (2012)

Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice
por: Margiani, Giulia, et al.
Publicado: (2022)

Cannabinoids and endocannabinoids as therapeutics for nervous system disorders: preclinical models and clinical studies
por: Duncan, R. Scott, et al.
Publicado: (2023)

Cannabinoids: Therapeutic Use in Clinical Practice
por: Pagano, Cristina, et al.
Publicado: (2022)

Editorial: Epigenetic insights into diagnostic and therapeutic applications
por: Fratta, Elisabetta, et al.
Publicado: (2023)

Exploring the association between brain-derived neurotrophic factor (BDNF) levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients
por: Isayeva, U., et al.
Publicado: (2022)

A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats
por: Goonawardena, Anushka V., et al.
Publicado: (2011)

Chronic Use of Synthetic Cannabinoids Is Associated With Impairment in Working Memory and Mental Flexibility
por: Cohen, Koby, et al.
Publicado: (2020)

Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
por: Kokona, Despina, et al.
Publicado: (2016)

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
por: Kibret, Berhanu Geresu, et al.
Publicado: (2022)

Incidence of inpatient cases with mental disorders due to use of cannabinoids in Germany: a nationwide evaluation
por: Gahr, Maximilian, et al.
Publicado: (2022)

Prospects for the Use of Cannabinoids in Psychiatric Disorders
por: Graczyk, Michał, et al.
Publicado: (2021)

Book Review: Cannabinoids and Neuropsychiatric Disorders
por: Murkar, Anthony L., et al.
Publicado: (2021)

Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids
por: Yasmin-Karim, Sayeda, et al.
Publicado: (2018)

The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer
por: Singh, Kanika, et al.
Publicado: (2021)

Special Issue: Therapeutic Potential for Cannabis and Cannabinoids
por: Raup-Konsavage, Wesley M.
Publicado: (2023)

Maternal Immune Activation Disrupts Dopamine System in the Offspring
por: Luchicchi, Antonio, et al.
Publicado: (2016)

Intraventricular recombinant alpha-interferon in subacute sclerosing panencephalitis
por: Cianchetti, C., et al.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_sisp33qkt2rae61lai23bpt2oj